Glaucomatous patients with anorexia nervosa may face conditions such as poor physical fitness during their daily lives, such as absorption and digestive disorders in the digestive system, and susceptibility to circulatory diseases. Traditional surgical treatment may not achieve ideal results for the needs of such patients. In view of this, the study aims to explore whether the combination of chlorpromazine and surgical treatment can bring better treatment methods and effects to patients with anorexia nervosa in glaucoma. Through in-depth analysis of the characteristics of chlorpromazine and the etiology of neuroanorexia in glaucoma patients, the study provided a new treatment method for such patients.

The study selected 60 glaucoma patients with anorexia nervosa as the research subjects and randomly divided them into an experimental group and a control group. The experimental group patients were treated with chlorpromazine combined with surgery, while the control group patients were treated with surgery only. The study used the Minnesota Multi-personality Inventory (MMPI) to evaluate the intervention of anorexia nervosa in glaucoma patients.

Before the experiment, there was no significant difference in the scores of anorexia nervosa between the two groups of patients (MMPI>60). After the experiment, patients in the experimental group showed significant improvement in anorexia nervosa, which was significantly lower than those in the control group (MMPI<40).

The combination of chlorpromazine and surgical treatment can significantly alleviate the neurological anorexia of glaucoma patients, which has a positive effect on their physical health.